1. Home
  2. CABO vs STTK Comparison

CABO vs STTK Comparison

Compare CABO & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cable One Inc.

CABO

Cable One Inc.

HOLD

Current Price

$75.88

Market Cap

540.0M

ML Signal

HOLD

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$7.03

Market Cap

569.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CABO
STTK
Founded
1980
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
540.0M
569.1M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
CABO
STTK
Price
$75.88
$7.03
Analyst Decision
Hold
Buy
Analyst Count
4
7
Target Price
$125.67
$10.00
AVG Volume (30 Days)
95.3K
424.3K
Earning Date
04-30-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
53.02
EPS
6.12
N/A
Revenue
$1,501,423,000.00
$1,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6.83
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$70.37
$0.71
52 Week High
$187.90
$8.33

Technical Indicators

Market Signals
Indicator
CABO
STTK
Relative Strength Index (RSI) 30.95 49.99
Support Level $70.37 $5.75
Resistance Level $117.15 $7.68
Average True Range (ATR) 7.87 0.52
MACD -2.78 -0.13
Stochastic Oscillator 5.71 17.27

Price Performance

Historical Comparison
CABO
STTK

About CABO Cable One Inc.

Cable One Inc is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. The company derives majority of its revenue from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: